These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


851 related items for PubMed ID: 2424425

  • 1. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R, Seitz R, Blanke H, Leititis J, Kesper HJ, Burghard R, Fuchs G, Lerch L.
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [Abstract] [Full Text] [Related]

  • 2. The clinical significance of alpha 1-antitrypsin-elastase (alpha 1AT-ELP) and alpha 2-antiplasmin-plasmin (alpha 2AP-PL) complexes for the differentiation of coagulation protein turnover: indications for plasma protein substitution in patients with septicaemia.
    Seitz R, Egbring R, Radtke KP, Wolf M, Fuchs G, Fischer J, Lerch L, Karges HE.
    Int J Tissue React; 1985 Feb; 7(4):321-8. PubMed ID: 2933357
    [Abstract] [Full Text] [Related]

  • 3. Improved prognosis of fulminant hepatic failure (FHF) after plasma derivative replacement therapy. Enhanced proteolysis of hemostatic proteins confirmed by proteinase-inhibitor complexes determination.
    Egbring R, Seitz R.
    Z Gastroenterol; 1990 Feb; 28(2):104-9. PubMed ID: 2138832
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Coagulation tests in septic surgical patients].
    Oberhofer D, Kucisec-Tepes N, Skok J, Vucić N, Cala K.
    Acta Med Croatica; 2004 Feb; 58(5):389-94. PubMed ID: 15756805
    [Abstract] [Full Text] [Related]

  • 6. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
    Okajima K.
    Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
    [Abstract] [Full Text] [Related]

  • 7. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
    Ohsato K, Okamoto K.
    Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
    [Abstract] [Full Text] [Related]

  • 8. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
    Mavrommatis AC, Theodoridis T, Economou M, Kotanidou A, El Ali M, Christopoulou-Kokkinou V, Zakynthinos SG.
    Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
    [Abstract] [Full Text] [Related]

  • 9. [Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC].
    Koyama T, Aoki N.
    Nihon Rinsho; 1993 Jan; 51(1):43-9. PubMed ID: 8433527
    [Abstract] [Full Text] [Related]

  • 10. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T, Saito H, Watanabe Y, Sato M, Murakawa E.
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [Abstract] [Full Text] [Related]

  • 11. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M, Roem D, Kamp AM, de Boer JP, Hack CE, ten Cate JW.
    Thromb Haemost; 1993 Feb 01; 69(2):141-6. PubMed ID: 7681223
    [Abstract] [Full Text] [Related]

  • 12. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
    Raaphorst J, Johan Groeneveld AB, Bossink AW, Erik Hack C.
    Thromb Haemost; 2001 Aug 01; 86(2):543-9. PubMed ID: 11522001
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M, Toh CH, Thachil J, Watson HG.
    Br J Haematol; 2009 Apr 01; 145(1):24-33. PubMed ID: 19222477
    [Abstract] [Full Text] [Related]

  • 16. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H, Scrobohaci ML, Ghorra P, Zini JM, Daniel MT, Castaigne S, Degos L.
    Leukemia; 1993 Jan 01; 7(1):2-9. PubMed ID: 8418375
    [Abstract] [Full Text] [Related]

  • 17. Immunological determination of proteinase inhibitor complexes (PICs) and their behaviour during plasma derivate treatment in septic infections.
    Egbring R, Seitz R, Blanke H, Menges T, Südhoff R, Stober T, Kolb G, Lerch L.
    Prog Clin Biol Res; 1989 Jan 01; 308():971-6. PubMed ID: 2789404
    [No Abstract] [Full Text] [Related]

  • 18. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock.
    Vervloet MG, Thijs LG, Hack CE.
    Semin Thromb Hemost; 1998 Jan 01; 24(1):33-44. PubMed ID: 9515778
    [Abstract] [Full Text] [Related]

  • 19. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T, Gando S, Mizugaki A, Yanagida Y, Jesmin S, Yokota H, Ieko M.
    Thromb Res; 2013 Jul 01; 132(1):e64-9. PubMed ID: 23726093
    [Abstract] [Full Text] [Related]

  • 20. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan 01; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 43.